|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/34 | |
| A61K 9/06 | |||
| A61K 9/00 | |||
| A61K 9/50 |
| (11) | Number of the document | 2806853 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13702182.0 |
| Date of filing the European patent application | 2013-01-22 | |
| (97) | Date of publication of the European application | 2014-12-03 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/022466 |
| Date | 2013-01-22 |
| (87) | Number | WO 2013/112434 |
| Date | 2013-08-01 |
| (30) | Number | Date | Country code |
| 201261589681 P | 2012-01-23 | US |
| (72) |
MARSH, David, A., US
RIVERS, Hongwen Ma, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | TIME RELEASED BIODEGRADABLE OR BIOERODIBLE MICROSPHERES OR MICROPARTICLES SUSPENDED IN A SOLIDIFYING DEPOT-FORMING INJECTABLE DRUG FORMULATION |
| TIME RELEASED BIODEGRADABLE OR BIOERODIBLE MICROSPHERES OR MICROPARTICLES SUSPENDED IN A SOLIDIFYING DEPOT-FORMING INJECTABLE DRUG FORMULATION |